Search research articles
Contact Us
Filters
Showing results (21-30 of 263) with videos related to
Page
of 27
Sort By:
Liver
|
November 26, 2002
Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma
Yujin Hoshida, Yasushi Shiratori, Masao Omata
Journal of Clinical Medicine
|
December 1, 2020
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
Naoto Kubota, Naoto Fujiwara, Yujin Hoshida
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 14, 2004
[Progression and risk factors for hepatocarcinogenesis in hepatitis C-related cirrhosis--viral factors, host factors, and others]
Yujin Hoshida, Naoya Kato, Masao Omata
Hepatology (Baltimore, Md.)
|
May 10, 2023
Matrisomic characterization of HCC to inform individualized patient management
Hiroaki Kanzaki, Courtney Katz, Yujin Hoshida
Hepatic Oncology
|
December 1, 2015
Molecular classification of hepatocellular carcinoma: potential therapeutic implications
Nicolas Goossens, Xiaochen Sun, Yujin Hoshida
Genomics Data
|
December 16, 2014
Prognostic gene signature profiles of hepatitis C-related early-stage liver cirrhosis
Anu Venkatesh, Xiaochen Sun, Yujin Hoshida
Expert Review of Precision Medicine and Drug Development
|
July 10, 2019
Use of big data in drug development for precision medicine: an update
Tongqi Qian, Shijia Zhu, Yujin Hoshida
Trends in Genetics : TIG
|
February 5, 2021
Transcriptome-Guided Design of Physiological Multilineage Liver Organoids
Shijia Zhu, Naoto Kubota, Yujin Hoshida
Advances in Cancer Research
|
August 12, 2022
Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts
Naoto Kubota, Naoto Fujiwara, Yujin Hoshida
Best Practice & Research. Clinical Gastroenterology
|
October 20, 2010
Inherited hepatocellular carcinoma
Augusto Villanueva, Pippa Newell, Yujin Hoshida
Page
of 27
Search research articles
Search
Showing results (21-30 of 263) with videos related to
Sort By:
Page
of 27
Liver
|
November 26, 2002
Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma
Yujin Hoshida, Yasushi Shiratori, Masao Omata
Journal of Clinical Medicine
|
December 1, 2020
Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk
Naoto Kubota, Naoto Fujiwara, Yujin Hoshida
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 14, 2004
[Progression and risk factors for hepatocarcinogenesis in hepatitis C-related cirrhosis--viral factors, host factors, and others]
Yujin Hoshida, Naoya Kato, Masao Omata
Hepatology (Baltimore, Md.)
|
May 10, 2023
Matrisomic characterization of HCC to inform individualized patient management
Hiroaki Kanzaki, Courtney Katz, Yujin Hoshida
Hepatic Oncology
|
December 1, 2015
Molecular classification of hepatocellular carcinoma: potential therapeutic implications
Nicolas Goossens, Xiaochen Sun, Yujin Hoshida
Genomics Data
|
December 16, 2014
Prognostic gene signature profiles of hepatitis C-related early-stage liver cirrhosis
Anu Venkatesh, Xiaochen Sun, Yujin Hoshida
Expert Review of Precision Medicine and Drug Development
|
July 10, 2019
Use of big data in drug development for precision medicine: an update
Tongqi Qian, Shijia Zhu, Yujin Hoshida
Trends in Genetics : TIG
|
February 5, 2021
Transcriptome-Guided Design of Physiological Multilineage Liver Organoids
Shijia Zhu, Naoto Kubota, Yujin Hoshida
Advances in Cancer Research
|
August 12, 2022
Liver cancer risk-predictive molecular biomarkers specific to clinico-epidemiological contexts
Naoto Kubota, Naoto Fujiwara, Yujin Hoshida
Best Practice & Research. Clinical Gastroenterology
|
October 20, 2010
Inherited hepatocellular carcinoma
Augusto Villanueva, Pippa Newell, Yujin Hoshida
Page
of 27